The startup develops a neurovascular device that utilizes fluoroscopic visualization to detect and treat cerebral aneurysms, enhancing the precision of interventions for both shallow and large aneurysms. This technology aims to improve treatment success rates, providing patients with more effective medical options.
Funding
$7.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for treating brain aneurysms, especially wide-necked bifurcation, side wall, unruptured & ruptured aneurysms, can lack precision, potentially leading to incomplete occlusion and recurrence. Existing intrasaccular devices may not conform well to complex aneurysm shapes, increasing the risk of complications.
Solution
Galaxy Therapeutics is developing the SEAL™ Embolization System, a novel dual-layer intrasaccular flow diverter designed to treat a range of aneurysm morphologies. The SEAL™ device is designed for treating wide-necked bifurcation, side wall, unruptured & ruptured aneurysms ranging in size from 2.5 to 19mm in width. Its high-density mesh promotes faster early thrombosis, while its ultra-soft, oversized design allows for conformability within the aneurysm sac. The system aims to improve treatment outcomes by providing a more complete and durable occlusion of the aneurysm.
Target Audience
The primary target audience includes neurointerventionalists and healthcare professionals specializing in the treatment of brain aneurysms.
Features
- Dual-layer intrasaccular flow diverter for enhanced aneurysm occlusion
- High-density mesh to accelerate early thrombosis
- Two unique shapes to accommodate diverse aneurysm morphologies
- Ultra-soft construction for optimal conformability and reduced risk of perforation
- Atraumatic leading tip for fast and easy placement without a lead-in marker band
- Simple sizing, with just 7 sizes to treat aneurysms from 2.5 to 19mm
- Fully visible under fluoroscopy for precise placement